Maynard Um
-
-
-
-
-
-
-
Caladrius Biosciences, Inc. (LSTA) Tops Q2 EPS by 10c
-
-
-
-
-
-
-
Lisata Therapeutics (LSTA) and WARPNINE Announce Encouraging Preliminary Results from the Phase 1b/2a iLSTA Trial Evaluating Certepetide in Locally Advanced Non-Resectable Pancreatic Ductal Adenocarci
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Lisata Therapeutics, Inc (LSTA)
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

